FAC Explorer

Audit 336550

FY End
2024-06-30
Total Expended
$6.61M
Findings
0
Programs
11
Organization: Monell Chemical Senses Center (PA)
Year: 2024 Accepted: 2025-01-08
Auditor: Kreischer Miller

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $392,072 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $187,677 Yes 0
93.121 Oral Diseases and Disorders Research $141,232 Yes 0
93.173 Research Related to Deafness and Communication Disorders $132,626 Yes 0
99.999 Swi-Dod-Dtra:subcontract No. N99070n $68,602 Yes 0
93.867 Vision Research $59,603 Yes 0
93.273 Alcohol Research Programs $42,275 Yes 0
47.084 Nsf Technology-Innovation and Partnerships $38,035 Yes 0
93.213 Research and Training in Complementary and Integrative Health $14,650 Yes 0
93.837 Cardiovascular Diseases Research $8,085 Yes 0
93.855 Allergy, Immunology and Transplantation Research $5,443 Yes 0

Contacts

Name Title Type
DJCTQA1PR7Q4 Danielle Coyne Auditee
2675194729 Steve Feimster Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying supplementary schedule of expenditures of federal awards includes the federal grant activity of Monell Chemical Senses Center (Monell) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). De Minimis Rate Used: N Rate Explanation: Monell has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.